Fitterfly, a healthtech company offering digital therapeutics (DTx), has raised $3.1 Mn in a Pre-Series A round led by Fireside Ventures, which now holds a significant stake in the startup. Notably, this is Fireside’s first bet in the telemedicine and healthtech segment.
The startup offers customised DTx programs for diabetes, obesity, pregnancy and child wellness. The funds would be used to deliver better patient outcomes at scale, creating awareness and expanding reach.
